Abstract
Malignancy is the most common cause of hypercalcemia among hospitalised patients and is frequently caused by elevations in parathyroid hormone-related peptide (PTHrP). The most common PTHrP-producing cancers are carcinomas of the head, neck and lung. Hypercalcemia can be the presenting sign of cancer and, in these cases, solid tumours are usually discovered on CT scan. In rare cases, lymphoma may also present with hypercalcemia. CT scan is less sensitive for lymphoma than for most solid tumours and the diagnosis may be missed. We present the case of a 69-year-old woman who presented with hypercalcemia in the setting of severe weight loss and elevated PTHrP. Oncological workup was stopped after unrevealing CT scans and an underlying lymphoma was missed. Our case emphasises the need for a comprehensive oncological workup for patients with unexplained hypercalcemia and elevated PTHrP, even when CT scans are unrevealing.
Reference13 articles.
1. Hypercalcemia Associated with Cancer
2. Prevalence of hypercalcemia among cancer patients in the United States;Gastanaga;Cancer Med,2016
3. Ravinder JS , Kaur R . Humoral hypercalcemia of malignancy: the case for parathyroid hormone-related protein, with caveats. bench matters. Clinical Laboratory News, 2016.
4. Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD);Ling;Br J Cancer,1995
5. Differential diagnosis of hypercalcemia;Lafferty;J Bone Miner Res,1991